Global brokerage firm Jefferies has reiterated its high-conviction 'Buy' recommendation on state-run defense behemoth Hindustan Aeronautics Limited (HAL), pegging an ambitious target price of ₹6,800 per share. The bullish outlook hinges on accelerated execution milestones, with HAL's top management expressing confidence in rolling out the indigenous Tejas Mark 1A fighter aircraft deliveries within the ongoing year. The Tejas Mark 1A program commands an estimated 43 percent share of HAL’s substantial total order book, serving as the primary multi-year valuation driver for the defense stock. Jefferies pointed out that execution risks have dropped markedly after HAL received 10 General Electric (GE) engines, alongside awarding the critical Tejas Mark 1 trainer contract targeted for formal delivery by September 18, 2026.

Bernstein Slashes PB Fintech by 53%: Regulatory Commission Caps Cloud Near-Term Growth

In a sharp contrarian reassessment, international research house Bernstein dramatically downgraded its price target on Policybazaar parent PB Fintech to ₹1,085 per share from its previous target of ₹2,310. The steep revision reflects stringent regulatory proposals targeting distributor remuneration and commission caps within general and health insurance segments. Bernstein warned that compressed distributor payouts in non-life insurance may fail to cover elevated customer acquisition and servicing costs, forcing PB Fintech to scale down general insurance retail distribution and pivot heavily toward pure-term life insurance products. While the brokerage maintains that the fintech aggregator has long-term structural value creation opportunities, the next 18 months present critical transition friction, with management pressured to deploy alternate monetization models to offset health commission compressions.

Institutional Calls on Financials, Aviation, and MedTech: UBS, Citi, and Jefferies View

Elsewhere on Dalal Street, UBS initiated a 'Neutral' stance on ICICI Lombard General Insurance with a price target of ₹1,930 per share, balancing underpenetrated motor and commercial risk verticals against regulatory headwinds, while noting the insurer's lean cost structure should cushion operating profitability. In the infrastructure space, Citi reaffirmed its 'Buy' call on GMR Airports with a target of ₹121 per share, citing surging passenger traffic growth, higher non-aeronautical retail spending, airline fleet expansions, and established regulatory capex recovery frameworks that have sustained core operating profitability since late 2025. Rounding out fresh coverage, Jefferies issued a glowing 'Buy' recommendation on healthcare innovator Molbio Diagnostics with a target price of ₹1,600, forecasting a 22 percent revenue CAGR and a robust 47 percent profit after tax (PAT) CAGR through fiscal 2029 driven by its proprietary point-of-care molecular diagnostics testing platforms.